Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials

from Mendelspod Podcast · host Theral Timpson

Guest:Janet, Woodcock, MD, Director, CDER, FDA Bio and Contact Info Listen (4:41) No agency charged with better translational outcomes This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Episode metadata supplied by the publisher feed · Published Nov 13, 2014

Embed this episode

Attribution link and audio player

NOW PLAYING

Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials

0:00 27:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Mendelspod Podcast?

This episode is 27 minutes long.

When was this Mendelspod Podcast episode published?

This episode was published on November 13, 2014.

Can I download this Mendelspod Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!